REGAAL NSE filing

Regaal Resources Q4 FY26 Earnings Call Transcript Released; Expansion Updates

The RealCase readHigh impact Positive

Regaal Resources Limited released its Q4 FY26 earnings call transcript. The company commissioned a major expansion on May 26, 2026, increasing crushing capacity to 1,650 TPD and adding derivative facilities. FY26 operating income was ₹1,134.2 crore, with PAT at ₹55.6 crore. A dividend of ₹0.25 per share is proposed. Further capex of ₹140 crore is planned for FY27.

Why it matters

The substantial capacity expansion, increased production capabilities, and positive financial results are material developments that are likely to have a significant impact on the company's future performance and investor perception.

The market read

The announcement details significant capacity expansion, improved financial performance, and a proposed dividend, all of which are positive indicators for the company.

Regaal Resources Limited has released the transcript of its Q4 and FY26 Earnings Conference Call, held on May 28, 2026. The call provided updates on the company's performance and strategic initiatives.

During the call, management highlighted the successful commissioning of a significant manufacturing expansion on May 26, 2026. This expansion has increased the crushing capacity to 1,650 tons per day, with the addition of new derivative facilities for liquid glucose (180 TPD) and maltodextrin powder (50 TPD). The captive co-generation power plant capacity has also been expanded by 10 MW, reaching a total of 15.8 MW. This expansion positions Regaal as the largest maize milling facility in Eastern India and strengthens its presence in higher value-added maize derivative products.

The company also provided financial highlights for FY26, with operating income at ₹1,134.2 crore and Profit After Tax (PAT) at ₹55.6 crore, resulting in a margin of 4.9%. The Board has recommended a dividend of ₹0.25 per share, subject to shareholder approval. For Q4 FY26, operating income was ₹244.6 crore, with operating EBITDA at ₹32.5 crore (13.3% margin) and PAT at ₹16.5 crore (6.8% margin).

Management discussed future plans, including the introduction of dextrose anhydrous, dextrose monohydrate, hydrol, and further additions to the modified starch range. The revised capex outlay for these expansions is approximately ₹540 crore, with an additional ₹140 crore expected to be invested during FY27. The company expects the new capacities to progressively ramp up to optimal operating levels over the coming weeks. Given the current inflection point with new capacities and evolving input cost dynamics, Regaal Resources will provide a formal earnings outlook by the end of H1 FY27.

Discussions also covered procurement strategies, working capital management, the Bihar Industrial Investment Promotion Policy (BIIPP) benefits, and the impact of raw material prices. The company noted a significant increase in 'other current assets' due to advances given for raw material procurement and warehouse storage.

Filing to action

What to do with a filing like this

Regaal Resources Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Regaal Resources Limited. Read the original for the full detail.

View original filing